Gland Pharma rises on getting nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)

08 Jan 2026 Evaluate

Gland Pharma is currently trading at Rs. 1727.20, up by 18.70 points or 1.09% from its previous closing of Rs. 1708.50 on the BSE.

The scrip opened at Rs. 1743.05 and has touched a high and low of Rs. 1795.85 and Rs. 1723.90 respectively. So far 32820 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2130.00 on 29-Jul-2025 and a 52 week low of Rs. 1200.00 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 1795.85 and Rs. 1675.00 respectively. The current market cap of the company is Rs. 29146.24 crore.

The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 40.55% and 7.63% respectively.

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). The product is therapeutically equivalent to the reference listed drug (RLD), Pataday Once Daily Relief, 0.7%, of Alcon Laboratories Inc (Alcon). This product is indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1680.75 -18.20 (-1.07%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×